Oral colistin sulfate in pigs: pharmacokinetics and effect on fecal Escherichia coli excretion of weaned pigs challenged with Escherichia coli F4 (K88)

Thumbnail Image
Date
2013-01-01
Authors
Rhouma, M.
Thériault, W.
Bergeron, Nadia
Lewandowski, S.
Fairbrother, J.
Beaudry, F.
Letellier, Ann
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Altmetrics
Authors
Research Projects
Organizational Units
Journal Issue
Is Version Of
Versions
Series
Series
International Conference on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork
Iowa State University Conferences and Symposia

The SafePork conference series began in 1996 to bring together international researchers, industry, and government agencies to discuss current Salmonella research and identify research needs pertaining to both pig and pork production. In subsequent years topics of research presented at these conferences expanded to include other chemical and biological hazards to pig and pork production.

Department
Abstract

Colistin sulfate (CS), a polymyxin antibiotic, is used in Canada for the treatment of post-weaning diarrhea in pigs as an alternative to neomycin. The aim of the present study was to evaluate some pharmcokinetics parameters of CS and its effect on the evolution of the intestinal Escherichia coli population in pigs challenged with enterotoxigenic E. coli (ETEC): F4.

Comments
Description
Keywords
Citation
Source
Copyright
Tue Jan 01 00:00:00 UTC 2013